Search Browse Earnings

Mirum Pharmaceuticals, Inc.

Nasdaq:MIRM

Pharmaceutical Preparations·FOSTER CITY, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Mirum Pharmaceuticals, Inc. — SlamSEC

Revenue

$186.4M

+141.8% YoY

FY 2025

Adj. EBITDA

-$98.3M

-52.8% margin

FY 2025

Net Income

-$163.4M

-87.7% margin

FY 2025

EPS (Diluted)

-$4.00

FY 2025

Stock Price

$90.66

+1.0%

2026-03-13

52W Range

$36.88 – $109.28

P/E Ratio

-22.7x

Market Cap

$5.5B

Cash

$222.5M

FY 2025

Total Debt

—

Net Cash

$222.5M

FY 2025

Enterprise Value

$5.2B

Debt / EBITDA

2.3x

FY 2025

EV / EBITDA

-53.4x

Employees

—